SRC-VRA H.B. 2192 78(R)    BILL ANALYSIS


Senate Research CenterH.B. 2192
78R11659 PEP-DBy: Keel (Van de Putte)
Administration
5/8/2003
Engrossed

DIGEST AND PURPOSE 

Over the last few years, federal law has been amended to add new
controlled substances to the federal penalty groups, resulting in
inconsistencies between Texas' current statutes and recently amended
federal law.  H.B. 2192 revises and updates provisions of the Texas
Controlled Substances Act relating to controlled substance penalty groups. 

RULEMAKING AUTHORITY

Rulemaking authority is transferred from the commissioner of public health
to the director of the Department of Public Safety in SECTION 1 (Section
481.002(22), Health and Safety Code) of this bill. 

SECTION BY SECTION ANALYSIS

SECTION 1.  Amends Section 481.002(22), Health and Safety Code, to
redefine "immediate precursor." 

SECTION 2.  Amends Section 481.034(d), Health and Safety Code, to require
the commissioner of public health (commissioner), in making a
determination regarding a substance, to consider certain factors,
including whether the substance is a controlled substance analogue,
chemical precursor, or an immediate precursor of a substance controlled
under this chapter.  

SECTION 3.  Amends Section 481.077, Health and Safety Code, by adding
Subsection (b-1), to provide that a substance that is a precursor of the
chemical precursor or the immediate precursor is not subject to control
solely because it is a precursor of the chemical precursor or the
immediate precursor, if the director of the Texas Department of Public
Safety (director) names a chemical substance as a chemical precursor for
purposes of Subsection (a) or designates a substance as an immediate
precursor. 

SECTION 4.  Amends Section 481.102, Health and Safety Code, to include
Dihydroetorphine in the list of controlled substances in Penalty Group 1.
Makes nonsubstantive changes. 

SECTION 5.  Amends Section 481.103(a), Health and Safety Code, to include
2, 5-dimethoxy4-(n)-propylthiophenethylamine (trade or other name:
2C-T-7);  N-benzylpiperazine (some trade or other names: BZP;
1-benzylpiperazine); and 1-(3-trifluoromethylphenyl) piperazine (trade or
other name: TFMPP) in the list of controlled substances in Penalty Group
2.   Deletes Ketamine from the list of Penalty Group 2 substances.  Makes
conforming changes.  

SECTION 6.  Amends Subchapter D, Chapter 481, Health and Safety Code, by
adding Section 481.106, as follows: 

Sec. 481.106.  CLASSIFICATION OF CONTROLLED SUBSTANCE ANALOGUE. Provides
that for the purposes of the prosecution of an offense under this
subchapter involving the manufacture, delivery, or possession of a
controlled substance, Penalty Groups 1, 1-A, and 2 include a controlled
substance analogue that has a chemical structure substantially similar to
the chemical structure of a controlled substance listed in the applicable
penalty group; or is specifically designed to produce an effect
substantially similar to, or greater than, a controlled substance listed
in the applicable penalty group. 

 SECTION 7.  Amends Section 481.123, Health and Safety Code, as follows:

Sec.  481.123.   New heading:  DEFENSE TO PROSECUTION FOR OFFENSE
INVOLVING CONTROLLED SUBSTANCE ANALOGUE.  (a)  Provides that it is an
affirmative defense to the prosecution of an offense under this subchapter
involving the manufacture, delivery, or possession of a controlled
substance analogue that the analogue was not in any part intended for
human consumption; was a substance for which there is an approved new drug
application under Section 505 of the Federal Food, Drug, and Cosmetic Act
(21 U.S.C. Section 355); or was a substance for which an exemption for
investigational use has been granted under Section 505 of the Federal
Food, Drug, and Cosmetic Act (21 U.S.C. Section 355), if the actor's
conduct with respect to the substance is in accord with the exemption.  

  (b)  Redesignates Subsection (h) as Subsection (b).

   Deletes Subsections (i) through (l). 

SECTION 8.  Amends Sections 481.181(a) and (b), Health and Safety Code, as
follows:  

(a)  Defines "reasonable time."  Requires the director to state the
purpose of the entry; display to the owner, operator, or agent in charge
of the premises appropriate credentials; and deliver a written notice of
inspection authority. 

 (b)  Authorizes the director to take certain actions.

SECTION 9.  Amends Section 481.182, Health and Safety Code, as follows:

Sec. 481.182.  New heading:  EVIDENTIARY RULES RELATING TO OFFER OF
DELIVERY.  Provides that for the purpose of establishing a delivery under
this chapter, proof of an offer to sell must be corroborated by a person
other than the person to whom the offer is made, or by evidence other than
a statement of the person to whom the offer is made.  Deletes text
referencing search warrants. 

SECTION 10.  Amends Section 481.183, Health and Safety Code, as follows:  

Sec.  481.183.  New heading: EVIDENTIARY RULES RELATING TO DRUG
PARAPHERNALIA.   (a)  Deletes text requiring corroborated evidence in
regard to the delivery of controlled substances.  Redesignates existing
Subsection (b) as (a). 

  (b)  Redesignates Subsection (c) as (b).

SECTION 11.  Amends Section 481.184(c), Health and Safety Code, to
stipulate that this chapter does not impose a liability on an authorized
state, county or municipal officer engaged in the lawful performance of
official, rather than the officer's, duties. 

SECTION 12.  Amends Section 481.186(b), Health and Safety Code, to
authorize the director to rely on certain information received from the
Federal Drug Enforcement Administration or, rather than and, a state
agency.  Makes a nonsubstantive change. 

SECTION 13.  Amends Article 18.02, Code of Criminal Procedure, to
authorize a search warrant to be issued to search for and seize certain
drug-related items. 

SECTION 14.  Repealer: Article 481.034(f), Health and Safety Code
(regarding establishment and modification of schedules by the
commissioner). 

SECTION 15.  Effective date: September 1, 2003.
   Makes application of this Act prospective.